DalsnaFinance › IPOs › Kailera Therapeutics › IPO
Kailera Therapeutics, Inc. completed its initial public offering on NASDAQ on April 17, 2026, pricing at $16.00 a share.
| Ticker | KLRA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | April 17, 2026 |
| Offering price | $16.00 |
| Shares offered | 39,062,500 |
| Total raised | $625M |
Kailera Therapeutics, Inc. sold 39,062,500 shares at $16.00 each on NASDAQ. Multiplied out, that is $625 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $625 million total recorded for the deal.
Measured by money raised, Kailera Therapeutics, Inc. was tied for the 38th largest (level with 1 other deal) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. It is one of 46 deals in that window to raise $500 million or more. The median deal in the same window raised $200 million, so this one was about 3.1 times the typical size.
Among the 342 listings on NASDAQ alone, it is tied for the 17th largest (level with 1 other listing).
April 2026 saw 30 completed IPOs in the site's data; by amount raised, Kailera Therapeutics, Inc. was the 5th largest of the 30 deals with a recorded size.
Its $16.00 offer price was tied for the 109th highest (level with 11 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Kailera Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Kailera Therapeutics, Inc.. This page is general information, not investment advice.